Nature Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2023-04-04 544068366 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：基础研究
经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。

101 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2021-04-18 victorywangz

审稿速度:12.0 | 投稿命中率:50.0
经验分享：Manuscript under consideration 23rd March 21
Contacting Potential Reviewers 23rd March 21
Manuscript under consideration 2nd March 21
Editor Assigned 2nd March 21
Manuscript submitted 27th February 21
Submission in process 27th February 21

362 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2018-08-24 bigapple001

donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好

727 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2024-01-04 ms2000000482637756 来自浙江省

偏重的研究方向：分子生物学;化学
经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了

347 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2023-04-12 14811d17m05暂无昵称来自广东省

偏重的研究方向：医学
经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了

209 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2023-01-04 ms6000000798925478 来自广东省

偏重的研究方向：消化;单细胞
经验分享：1-1 submitted
1-3 editor assigned
1-3 manuscript under consideration
1-4 contacting potential reviewers
希望有个好结果

193 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2023-02-13 ms6000000798925478 来自广东省

偏重的研究方向：消化
经验分享：Stage Start Date
Manuscript under consideration 29th January 23
19th January 23
Manuscript under consideration 4th January 23
Contacting Potential Reviewers 4th January 23
Manuscript under consideration 3rd January 23
Editor Assigned 3rd January 23
Manuscript submitted 1st January 23
各位大佬帮忙看看，这是啥情况，投出去42天了

131 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2022-07-07 小闪电

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：医学;肿瘤
经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌

237 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2019-12-13 nianhuaifeiai

10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表::
请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表:
请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration

155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration

327 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2123619, encodeId=16a621236190f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：23.1.4号投稿，23.2.22号送审，一个月后审稿意见回来，编辑决定被拒，比较心塞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53363077632, createdName=544068366, createdTime=Tue Apr 04 08:34:01 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=958003, encodeId=b2d3958003e4, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Manuscript under consideration 23rd March 21 Contacting Potential Reviewers 23rd March 21 Manuscript under consideration 2nd March 21 Editor Assigned 2nd March 21 Manuscript submitted 27th February 21 Submission in process 27th February 21 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7c45481669, createdName=victorywangz, createdTime=Sun Apr 18 12:11:47 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560419, encodeId=e3ff560419d4, content=donotcropthemembrane意思是全膜如果没有全膜要把你剪开曝光的膜的结果全部拼在一起上传给责任编辑接收以后责任编辑才会问你要原始数据一开始不用但是要准备好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=727, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri Aug 24 22:52:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179134, encodeId=a50a21e91343b, content=偏重的研究方向：分子生物学;化学 经验分享： Stage Start Date End Date Approximate Duration Manuscript under consideration 23rd December 23 Editor Assigned 23rd December 23 Manuscript submitted 20th December 23 Submission in process 19th December 23 这速度是真的慢，编辑决定都11天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aac5396279, createdName=ms2000000482637756, createdTime=Thu Jan 04 02:34:25 CST 2024, time=2024-01-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2125394, encodeId=53492125394b8, content=偏重的研究方向：医学 经验分享：如果没送外审，一般多久拒搞啊？投了有一个星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3da55266136, createdName=14811d17m05暂无昵称, createdTime=Wed Apr 12 10:08:46 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108823, encodeId=a508210882371, content=偏重的研究方向：消化;单细胞 经验分享：1-1 submitted 1-3 editor assigned 1-3 manuscript under consideration 1-4 contacting potential reviewers 希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Jan 04 20:22:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114325, encodeId=d8bd211432520, content=偏重的研究方向：消化 经验分享：Stage Start Date Manuscript under consideration 29th January 23 19th January 23 Manuscript under consideration 4th January 23 Contacting Potential Reviewers 4th January 23 Manuscript under consideration 3rd January 23 Editor Assigned 3rd January 23 Manuscript submitted 1st January 23 各位大佬帮忙看看，这是啥情况，投出去42天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Mon Feb 13 00:49:31 CST 2023, time=2023-02-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231160, encodeId=f062123116067, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：All Reviewers Assigned 到下一阶段一般要多久呢？心慌慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220103/122ad3825e5a4e0ea89b235c10dcb453/f98b80edaa094ed3a0c12b250c44485d.png, createdBy=40a75193524, createdName=小闪电, createdTime=Thu Jul 07 15:04:17 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581448, encodeId=21ec581448f0, content=10.14号送审，到今天仍然没有返回审稿意见……155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration155****4772 2019-12-05 00:00:00 发表: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, beContent=155****4772 2019-12-05 发表:: 请问送审后状态会变吗？我收到编辑说送审的邮件了，但是状态还是under consideration, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25b21716552, createdName=nianhuaifeiai, createdTime=Fri Dec 13 00:00:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081411, encodeId=e1f2108141164, content=不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/04e44676f6307190674241bb49822e9f.jpg, createdBy=315f2132734, createdName=酱油和醋, createdTime=Sat Dec 18 05:00:26 CST 2021, time=2021-12-18, status=1, ipAttribution=)]

2021-12-18 酱油和醋

不知道是不是因为COVID-19，整个流程巨慢，前前后后折腾了一年。

417 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务